… review summarizes and compares the pharmacokinetics and pharmacodynamics of the
integrase strand transfer inhibitor agents, and describes specific pharmacokinetic considerations …

… This review summarizes the clinical pharmacokinetics of the three INSTIs currently
approved by the US Food and Drug Administration (FDA) for treatment of HIV in adult patients. …

… review, we aimed to summarize the pre-clinical and clinical … in the pharmacokinetics of
cabotegravir when comparing the two … inhibitor of HIV-1 integrase-catalyzed viral cDNA strand …

… in INSTIs for HIV-1 treatment, we focus our review on the retroviral integrase, development
of … BIC also displays an improved resistance profile over RAL and EVG, comparable with that …

… This article reviews current literature on the clinical pharmacology of INSTIs, … recent
comprehensive review for additional information related to the comparative clinical pharmacokinetics …

… non-inferiority designed comparative clinical trials, which led … HIV-1 RNA at day 8 and the
proportion of subjects with HIV-1 … Clinical pharmacology of the HIV integrase strand transfer …

… The integrase strand transfer inhibitor (INSTI)-containing regimens are currently considered
as … This review provides a summary of pharmacokinetic interactions with INSTIs and future …

… review utilizing the keywords of “integrase strand transfer … DTG/RPV group in comparison to
the current ART regimen (CAR… with a high genetic barrier to HIV-1 resistance [38]. Bictegravir …

… with HIV are the integrase strand transfer inhibitors (INSTIs). … favorable pharmacokinetic
and pharmacodynamic properties, … This review summarizes the current use of INSTIs in adults …

… Clinical efficacy comparing coadministration of … this review are overall not clinically meaningful
with respect to raltegravir's safety and efficacy profile. Raltegravir's clinical pharmacology …